Cargando…

P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes

Detalles Bibliográficos
Autores principales:	Saubi, N, Im, E, Fernandez-Lloris, R, Gil, O, Cardona, P, Gatell, J, Hanke, T, Joseph, J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767802/ http://dx.doi.org/10.1186/1742-4690-6-S3-P299

Ejemplares similares

Newborn Mice Vaccination with BCG.HIVA(222) + MVA.HIVA Enhances HIV-1-Specific Immune Responses: Influence of Age and Immunization Routes
por: Saubi, Narcís, et al.
Publicado: (2011)

A Phase I Randomized Clinical Trial of Candidate Human Immunodeficiency Virus type 1 Vaccine MVA.HIVA Administered to Gambian Infants
por: Afolabi, Muhammed O., et al.
Publicado: (2013)

Pre-clinical development of BCG.HIVA(CAT) strain, an antibiotic-free selection strain for HIV-TB pediatric vaccine
por: Saubi, N, et al.
Publicado: (2012)

Pre-Clinical Development of BCG.HIVA(CAT), an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG
por: Saubi, Narcís, et al.
Publicado: (2012)

Preclinical development of BCG.HIVA(2auxo.int), harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity
por: Mahant, Aakash, et al.
Publicado: (2017)

PedVacc 002: A phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi
por: Njuguna, Irene N., et al.
Publicado: (2014)

Lost bioscapes: Floristic and arthropod diversity coincident with 12(th) century Polynesian settlement, Nuku Hiva, Marquesas Islands
por: Allen, Melinda S., et al.
Publicado: (2022)

Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice
por: Saubi, Narcís, et al.
Publicado: (2020)

Toxicological Investigations on the Sea Urchin Tripneustes gratilla (Toxopneustidae, Echinoid) from Anaho Bay (Nuku Hiva, French Polynesia): Evidence for the Presence of Pacific Ciguatoxins
por: Darius, Hélène Taiana, et al.
Publicado: (2018)

Assessment of Ciguatera and Other Phycotoxin-Related Risks in Anaho Bay (Nuku Hiva Island, French Polynesia): Molecular, Toxicological, and Chemical Analyses of Passive Samplers
por: Roué, Mélanie, et al.
Publicado: (2020)

Molecular Characterization of Heterologous HIV-1gp120 Gene Expression Disruption in Mycobacterium bovis BCG Host Strain: A Critical Issue for Engineering Mycobacterial Based-Vaccine Vectors
por: Joseph, Joan, et al.
Publicado: (2010)

Tectus niloticus (Tegulidae, Gastropod) as a Novel Vector of Ciguatera Poisoning: Detection of Pacific Ciguatoxins in Toxic Samples from Nuku Hiva Island (French Polynesia)
por: Darius, Hélène Taiana, et al.
Publicado: (2017)

Tectus niloticus (Tegulidae, Gastropod) as a Novel Vector of Ciguatera Poisoning: Clinical Characterization and Follow-Up of a Mass Poisoning Event in Nuku Hiva Island (French Polynesia)
por: Gatti, Clémence Mahana iti, et al.
Publicado: (2018)

Engineering new mycobacterial vaccine design for HIV–TB pediatric vaccine vectored by lysine auxotroph of BCG
por: Saubi, Narcís, et al.
Publicado: (2014)

MVA85A vaccine to enhance BCG for preventing tuberculosis
por: Kashangura, Rufaro, et al.
Publicado: (2019)

Evaluation of a Human BCG Challenge Model to Assess Antimycobacterial Immunity Induced by BCG and a Candidate Tuberculosis Vaccine, MVA85A, Alone and in Combination
por: Harris, Stephanie A., et al.
Publicado: (2014)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Interleukin-17 in Antifungal Immunity
por: Sparber, Florian, et al.
Publicado: (2019)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

A prime-boost immunization with rBCG expressing HIV-1 Gag, RT and gp120 and SAAVI MVA-C elicits immune responses in blood and MALT of rhesus macaques
por: Chege, GK, et al.
Publicado: (2012)

Th17 Cells and IL-17 in Protective Immunity to Vaginal Candidiasis
por: Pietrella, Donatella, et al.
Publicado: (2011)

Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study
por: Sanchez, Jorge, et al.
Publicado: (2020)

P19-53 LB. Priming with recombinant BCG expressing HIV-1 Gag or RT and boosting with recombinant MVA induces an effective immune response in mice
por: Stutz, H, et al.
Publicado: (2009)

IL-17 cytokines in immunity and inflammation
por: Jin, Wei, et al.
Publicado: (2013)

Th17 Cells in Immunity and Autoimmunity
por: Bedoya, Simone Kennedy, et al.
Publicado: (2013)

Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route
por: Xu, Zhengzhong, et al.
Publicado: (2023)

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1
por: Fletcher, Helen A., et al.
Publicado: (2008)

Increased Number of Tc17 and Correlation with Th17 Cells in Patients with Immune Thrombocytopenia
por: Hu, Yu, et al.
Publicado: (2011)

Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy
por: Bilska, Monika, et al.
Publicado: (2020)

A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19
por: Singh, Shivani, et al.
Publicado: (2022)

Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
por: Kilpeläinen, Athina, et al.
Publicado: (2019)

Th17-type immunity and inflammation of aging
por: Merino, Kristen M., et al.
Publicado: (2021)

IL-17: Balancing Protective Immunity and Pathogenesis
por: Sun, Lu, et al.
Publicado: (2023)

The Humoral Immune Response to BCG Vaccination
por: Tanner, Rachel, et al.
Publicado: (2019)

Augmented Th17-Type Immune Responses in Preterm Neonates Exposed to Histologic Chorioamnionitis: Chorioamnionitis and Th17-type immunity
por: Rito, Daniel C., et al.
Publicado: (2016)

The Role of Th17 Cells and IL-17 in Th2 Immune Responses of Allergic Conjunctivitis
por: Meng, Xiang-Tian, et al.
Publicado: (2020)

Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
por: C. Guardo, Alberto, et al.
Publicado: (2017)

Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
por: Guardo, Alberto C., et al.
Publicado: (2018)

Immune regulation of bone loss by Th17 cells
por: Adamopoulos, Iannis E, et al.
Publicado: (2008)

Acinetobacter baumannii Infection and IL-17 Mediated Immunity
por: Yan, Zihe, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rvpgrt7n4bjv35jdjkmie9leci